The Patent Finder

Introgen Therapeutics, Inc.

Also on record
Records under this name other than patents Introgen Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Introgen Therapeutics, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,668,905P53 vaccines for the treatment of cancers
Formerly held
Lapsed on the fee record
Ended Mar 11, 2026 · High confidence
Lapsed on the fee recordEnded Mar 11, 2026High confidence
US 8,034,790Use of MDA-7 to inhibit pathogenic infectious organisms
Formerly held
Term ended
Term ended Mar 26, 2025 · USPTO record
Term endedTerm ended Mar 26, 2025USPTO record
US 9,428,768Method for the production and purification of adenoviral vectors
Term ended
Term ended Nov 4, 2023 · USPTO record
Term endedTerm ended Nov 4, 2023USPTO record
US 7,235,391Formulation of adenovirus for gene therapy
Formerly held
Term ended
Term ended Jul 8, 2023 · USPTO record
Term endedTerm ended Jul 8, 2023USPTO record
US 7,419,808Methods and compositions for the production of adenoviral vectors
Formerly held
Term ended
Term ended May 15, 2023 · USPTO record
Term endedTerm ended May 15, 2023USPTO record
US 7,732,129Method for the production and purification of adenoviral vectors
Formerly held
Lapsed on the fee record
Ended Jun 8, 2022 · USPTO record
Lapsed on the fee recordEnded Jun 8, 2022USPTO record
US 7,888,097Formulation for adenovirus storage
Formerly held
Term ended
Term ended Feb 12, 2021 · USPTO record
Term endedTerm ended Feb 12, 2021USPTO record
US 7,888,096Liquid adenovirus formulations
Formerly held
Term ended
Term ended Jan 3, 2021 · USPTO record
Term endedTerm ended Jan 3, 2021USPTO record
US 10,293,056Methods and compositions for non-viral gene therapy for treatment of hyperproliferative diseases
Formerly held
Term ended
Term ended May 24, 2020 · USPTO record
Term endedTerm ended May 24, 2020USPTO record
US 6,689,600Formulation of adenovirus for gene therapy
Formerly held
Term ended
Term ended Nov 16, 2019 · USPTO record
Term endedTerm ended Nov 16, 2019USPTO record
10 of 16 patents shown.
Pro members see all 16.
Pro members: see all 16 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited